View Older Stories View More Recent Stories
-
AT&T (T) PT Lowered to $30 at RBC Capital
-
GE Vernova (GEV) PT Raised to $630 at RBC Capital, 'Another Strong Quarter with Accretive Acquisition'
-
RBC Capital on Western Alliance Bancorporation (WAL) Earnings: 'consistent credit outlook and impressive deposit quarter'
-
RBC Capital Upgrades Regis Healthcare Ltd. (REG:AU) to Outperform
-
RBC Capital Reiterates Outperform Rating on Tesla (TSLA)
-
Tamboran Resources prices $48.8 million public offering at $21 per share
-
Tamboran Resources prices $48.8 million public stock offering
-
Tamboran Resources Corporation Pricing of Public Offering of Common Stock
-
Woodside Announces Louisiana LNG Partnership With Williams
-
Tamboran Resources launches public offering of 2.3 million shares
-
Tamboran Resources Corporation Public Offering of Common Stock
-
Veris Residential, Inc. Reports Third Quarter 2025 Results
-
CWAN to Participate in Upcoming Investor Conferences in Fourth Quarter 2025
-
RBC Capital on Jazz Pharmaceuticals (JAZZ): 'we would be buyers on the potential upcoming positive ph.III zanidatimab data in GEA'
-
Alkermes (ALKS) PT Raised to $47 at RBC Capital
-
Nurix (NRIX) PT Raised to $29 at RBC Capital
-
Pegasystems (PEGA) PT Raised to $80 at RBC Capital
-
Taylor Morrison Home (TMHC) PT Lowered to $68 at RBC Capital
-
RBC on Gilead Sciences (GILD): 'Next-Gen HIV Drug Appears Terminated'
-
RBC on Vertiv Holdings Co. (VRT): 'we would expect to see +MSD%-HSD% relative share outperformance in shares today'
-
RBC on Lennox International (LII): 'we would not be surprised to see a -LSD% relative underperformance in shares today'
-
US chemical firms set for another weak quarter on China-led supply glut, tariffs
-
Gold miners set for bumper profits after bullion's record rally
-
General Motors (GM) PT Raised to $86 at RBC Capital
-
AGNC Investment Corp (AGNC) PT Raised to $11 at RBC Capital
-
Galapagos NV (GLPG) PT Raised to $28 at RBC Capital
-
Crown Holdings (CCK) PT Raised at RBC Capital on 'Q3 Beat and Raise'
-
Pentair (PNR) PT Raised to $124 at RBC Capital
-
ProMIS Neurosciences (PMN) Appoints Dr. Slanix Paul Alex to Board
-
ProMIS Neurosciences Strengthens Board with Appointment of Slanix Paul Alex, Pharm.D., President and Portfolio Manager, Public Equity of Ally Bridge Group
-
3M (MMM) PT Raised to $130 at RBC Capital
-
Badger Meter (BMI) PT Lowered to $229 at RBC Capital
-
Intuitive Surgical (ISRG) PT Raised to $625 at RBC Capital
-
Celestica (CLS) PT Raised to $315 at RBC Capital
-
RBC Capital Upgrades Halliburton (HAL) to Outperform
-
Aveanna prices 10 million share secondary offering at $9.00 per share
-
Aveanna Announces Pricing of Secondary Offering of Common Stock
-
RBC Capital Starts Deere (DE) at Outperform
-
RBC Capital Starts United Rentals (URI) at Outperform
-
RBC Capital Starts Caterpillar (CAT) at Sector Perform
-
Aveanna stockholders launch 10 million share secondary offering
-
Aveanna Announces Launch of Secondary Offering of Common Stock
-
Primaris REIT Announces Closing of Over-Allotment Option
-
RBC Capital's Best Ideas and Q3/25 Preview from North American Diversified Financials
-
RBC Capital on Valvoline (VVV): 'Shares Feel Relatively De-Risked'
-
RBC Capital Reiterates Outperform Rating on 4D Molecular Therapeutics (FDMT)
-
CorMedix (CRMD) PT Raised to $22 at RBC Capital
-
Ideaya Biosciences (IDYA) PT Raised to $41 at RBC Capital
-
RBC Capital Starts REA Group Ltd. (REA:AU) (RPGRY) at Outperform
-
SavATree Appoints Ryan Berk as Chief Executive Officer
